oral non-prodrug thrombin (FIIa) inhibitor to treat thrombosis, oral bioavailability in HV from internal library HTS, SBDD, opt. vs. PXR J. Med. Chem., Oct. 27, 2020 Bayer AG, Wuppertal, DE